Literature DB >> 1678707

Central alpha 2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine.

J M Savola1, R Virtanen.   

Abstract

To determine whether different alpha 2-adrenoceptor-mediated functions have different stereochemical requirements in the central nervous system, we studied the pharmacological activities of the purified optical enantiomers of medetomidine (dl-4-[1(2,3-dimethylphenyl)ethyl]-1H-imidazole), a specific and selective agonist of alpha 2-adrenoceptors. We found that dexmedetomidine (the dextro enantiomer) had the pharmacological activity of medetomidine. Dexmedetomidine had hypotensive and bradycardic actions in anaesthetized rats as well as sedative (decreased spontaneous locomotor activity and prolonged sleep induced by hexobarbital in rats), analgesic (attenuated a writhing response induced by acetic acid in mice) and midriatic actions in rats. The potency of dexmedetomidine was slightly greater than that of medetomidine. 1-Medetomidine was generally without pharmacological activity, but it showed some sedative and analgesic properties at high doses. Although the findings obtained with l-medetomidine might indicate some deviation from strict homogeneity, these experiments demonstrate that the different alpha 2-adrenoceptor-mediated functions have similar stereochemical requirements in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678707     DOI: 10.1016/0014-2999(91)90535-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  27 in total

1.  High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation.

Authors:  Toshifumi Kosugi; Kotaro Mizuta; Tsugumi Fujita; Mikio Nakashima; Eiichi Kumamoto
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Effects of the menstrual cycle on bispectral index and anesthetic requirement in patients with preoperative intravenous dexmedetomidine following propofol induction.

Authors:  Xiaomin Zhou; Tingting Wang; Shaoqiang Huang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  Dexmedetomidine for transport of a spontaneously breathing combative child.

Authors:  Kevin M Watt; Jason Walgos; Ira M Cheifetz; David A Turner
Journal:  Pediatrics       Date:  2012-08-13       Impact factor: 7.124

4.  Evaluation of the muscular relaxant effect of dexmedetomidine or medetomidine in cats.

Authors:  P Scrollavezza; A M Tambella; C Vullo; A Palumbo Piccionello
Journal:  Vet Res Commun       Date:  2009-09       Impact factor: 2.459

5.  Dexmedetomidine.

Authors:  N Bhana; K L Goa; K J McClellan
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

6.  Azi-medetomidine: Synthesis and Characterization of a Novel α2 Adrenergic Photoaffinity Ligand.

Authors:  Andrew R McKinstry-Wu; Kellie A Woll; Thomas T Joseph; Weiming Bu; E Railey White; Natarajan V Bhanu; Benjamin A Garcia; Grace Brannigan; William P Dailey; Roderic G Eckenhoff
Journal:  ACS Chem Neurosci       Date:  2019-11-05       Impact factor: 4.418

7.  Contrasting effects of the imidazol(in)e alpha 2-adrenoceptor agonists, medetomidine, clonidine and UK 14,304 on extraneuronal levels of noradrenaline in the rat frontal cortex: evaluation using in vivo microdialysis and synaptosomal uptake studies.

Authors:  J W Dalley; S C Stanford
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

Review 8.  A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice.

Authors:  Melissa D Sinclair
Journal:  Can Vet J       Date:  2003-11       Impact factor: 1.008

9.  The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.

Authors:  Antti Haapalinna; Tiina Leino; Esa Heinonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

10.  Action of dexmedetomidine on the substantia gelatinosa neurons of the rat spinal cord.

Authors:  Hideaki Ishii; Tatsuro Kohno; Tomohiro Yamakura; Miho Ikoma; Hiroshi Baba
Journal:  Eur J Neurosci       Date:  2008-06-01       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.